期刊文献+

应用人胰岛素降糖治疗可作为适合中国现有国情的选择 被引量:1

Human insulin is a suitable choice for treatment of Chinese diabetic patients
原文传递
导出
摘要 治疗糖尿病的药物在不断更新换代,一味追求昂贵新药的做法并不现实,而应寻求更加具有成本效益、安全的治疗方案。本文通过分析糖尿病治疗中胰岛素起始治疗的时机,并对起始治疗方案进行分析,同时比较了胰岛素类似物、人胰岛素等不同的胰岛素治疗选择,在肯定人胰岛素疗效与安全性的同时,更指出其符合成本效益,可作为适应我国当前经济现状的治疗选择。 Newer drugs have been continuously brought to the market during the past years,it is more reasonable to seek for safe and cost-effective therapy rather than expensive new agents,considering the increasing population of diabetic patients and the current socia-economical conditions of our country.This review highly recommended early initiation of insulin therapy by analyzing the timing of insulin initiation and options of insulin products.Different insulin products such as insulin analogue versus recombinant human insulin are compared in terms of efficacy,safety and cost-effectiveness.Conclusion is that human insulin is a cost-effective treatment option better suited to China's current situation with satisfying safety and efficacy.
作者 冯凭
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2013年第11期1054-1056,共3页 Chinese Journal of Diabetes
关键词 人胰岛素 药物经济学 中国医疗支出的负担 Human insulin Cost effectiveness Chinese medical expenditure burden
  • 引文网络
  • 相关文献

参考文献16

  • 1Weng JP, Li YB,Xu W, et al. Effect of intensive insulin thera-py on p-cell function and glycaemic control in patients with newlydiagnosed type 2 diabetes : a multicentre randomised parallel-group trial. Lancet,2008,371: 1753-1760.
  • 2李延兵,翁建平,许雯,陈小华,廖志红,姚斌,邓婉萍,欧香忠,胡国亮.短期持续胰岛素输注治疗对初诊2型糖尿病患者胰岛β细胞功能的影响[J].中国糖尿病杂志,2003,11(1):10-15. 被引量:777
  • 3祝方,纪立农,韩学尧,朱宇,张红杰,周翔海,陈静,蔡晓陵,张明霞.短期胰岛素强化治疗诱导初诊2型糖尿病患者血糖长期良好控制的临床试验[J].中国糖尿病杂志,2003,11(1):5-9. 被引量:856
  • 4短期胰岛素强化治疗在2型糖尿病治疗中的作用[J].中国糖尿病杂志,2003,11(1):9-9. 被引量:1
  • 5中华医学会糖尿病学分会.中国2型糖尿病防治指南.2010年版.北京:北京大学医学出版社,2010.
  • 6Inzucchi SE, Bergenstal RM, Buse JB. et al. Management of hy-perglycaemia in type 2 diabetes: a patient-centered approach: po-sition statement of the American Diabetes Association (ADA)and the European Association for the Study of Diabetes (EASD).Diabetes Care,2012,35:1364-1379.
  • 7Owens DR. Stepwise intensification of insulin therapy in type 2diabetes management-exploring teach the concept of the basal-plus approach in clinical practice. Diabet Med,2013,30{276-288.
  • 8Rys P,Pankiewicz O, rach K, et al. Efficacy and safety compar-ison of rapid-acting insulin aspart and regular human insulin inthe treatment of type 1 and type 2 diabetes mellitus: a systematicreview. Diabetes Metab.2011,37 : 190-200.
  • 9Davidson JA, Liebl A, Christiansen JSt et al. Risk for nocturnalhypoglycemia with biphasic insulin aspart 30 compared with bi-phasic human insulin 30 in adults with type 2 diabetes mellitus: ameta-analysis. Clin Ther, 2009,31: 1641-1651.
  • 10Yang W,Lu J, Weng J,et al. Prevalence of diabetes amongmen and women in Chinai N Engl J Med, 2010,362:1090-1101.

二级参考文献29

  • 1金其林,宋晓敏,李锐,耿国柱,王新巧.上海市不同等级医院Ⅱ型糖尿病病人住院费用特征分析[J].中国医院,2006,10(7):29-32. 被引量:13
  • 2王建生,金水高.糖尿病的疾病负担分析[J].中华预防医学杂志,2007,41(3):186-188. 被引量:34
  • 3World Health Organization. Definition, diagnosis and classifictions of diabetes mellitus and its complications [J]. Report of a WHO consultation, Part 1: Diagnosis and classification of diabetes mellitus.Geneva: WHO, 1999.
  • 4Centers for Disease Control and Prevention.National diabetes fact sheet:general information and national estimates on diabetes in United States,2002 [J]. Atlantal:US Department of Health and Human Services, Centers for Disease Control and Prevention,2003.
  • 5潘长玉.糖尿病与社会保健系统:经济和社会成本[A]//Joslin.糖尿病学.第14版.北京:人民卫生出版社,2007:807-823.
  • 6American Diabetes Association.Economic cost of diabetes in the United States in 2002[J]. Diabetes Care, 2003, 26:217- 232.
  • 7《中国型糖尿病防治指南》编写组.中国2型糖尿病防治指南[M].北京:北京大学出版社,2007.
  • 8Gu D, Reynolds K, Duan X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population : International collaborative study of cardiovascular Disease in Asia [ J ]. Diabetologia, 2003, 46(9) : 1190-1198.
  • 9Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002 [ J ]. Diabetes Care, 2003, 26(3) : 917-932.
  • 10Ichikawa K, Yamato T, Ojima K, et al. Effect of KAD 21229,a novel hypoglycemic agent on plasma glucose levels after meal load in type 2 diabetes rats [ J ]. Clin Exp Pharmacol Physiol, 2002, 29(526): 423-427.

共引文献1335

同被引文献1

引证文献1

;
使用帮助 返回顶部